Filter Results :

Your search for T-Cell returned 29 reports

Sort by


T-Cell Leukemia - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by ...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with comparativ...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stage...

$ 2,000.00

Read More

T-Cell Lymphomas - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘T-Cell Lymphomas - Pipeline Review, H2 2014’, provides an overview of the T-Cell Lymphomas’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Lymphomas, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Cutaneous T-Cell Lymphoma-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cutaneous T-Cell Lymphoma. This report provides ...

$ 1,250.00

Read More

T-Cell Lymphomas-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'T-Cell Lymphomas-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under T-Cell Lymphomas. This report provides information on the...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphomas (PTCL). Thi...

$ 1,250.00

Read More

T-Cell Leukemia-Pipeline Insights, 2014

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'T-Cell Leukemia-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under T-Cell Leukemia. This report provides information on the t...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'Cutaneous T-Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for A...

$ 2,000.00

Read More

T-Cell Lymphomas Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'T-Cell Lymphomas- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufa...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'Peripheral T-Cell Lymphomas (PTCL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understand...

$ 2,000.00

Read More

T-Cell Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'T-Cell Leukemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufac...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014

31 Jul 2014  |  Published by:  Global Markets Direct
Summary‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with comparativ...

$ 2,000.00

Read More

T-Cell Leukemia - Pipeline Review, H2 2014

31 Jul 2014  |  Published by:  Global Markets Direct
Summary‘T-Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by ...

$ 2,000.00

Read More

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014

21 May 2014  |  Published by:  GlobalData
Summary“T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment...

$ 2,500.00

Read More
Total 29 records.